Comparison of mucosal and parenteral immunisation in two animal models of pneumococcal infection: Otitis media and acute pneumonia

Vaccine

Volumn 25, Issue 13, 2007, Pages 2471-2477

  Cripps, Allan W ^a   Kyd, Jennelle M ^b  

^a GRIFFITH UNIVERSITY   (Australia)

^b CENTRAL QUEENSLAND UNIVERSITY   (Australia)

Author keywords

Animal models; Immunisation; Otitis media; Pneumonia; Streptococcus pneumoniae

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; INTERLEUKIN 1BETA; PNEUMOCOCCUS VACCINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFICACY; IMMUNE RESPONSE; IMMUNIZATION; INFLAMMATION; LEUKOCYTE; LOBAR PNEUMONIA; LUNG LAVAGE; MALE; MIDDLE EAR; MOUSE; NONHUMAN; OTITIS MEDIA; PRIORITY JOURNAL; RAT; SENSITIVITY ANALYSIS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; UPREGULATION;

ANIMALS; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION ROUTES; IMMUNOGLOBULIN G; INTERLEUKIN-1BETA; LEUKOCYTE COUNT; MALE; MICE; MICE, INBRED BALB C; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATORY MUCOSA; STREPTOCOCCUS PNEUMONIAE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33847690662     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.09.022     Document Type: Article

References (14)

1. Beck R.W. A chronology of microbiology in historical context (2000), American Society for Microbiology Press, Washington
2. Jomaa M., Kyd J.M., and Cripps A.W. Mucosal immunization with novel Streptococcus pneumoniae protein antigens enhances bacterial clearance in an acute mouse lung infection model. FEMS Immunol Med Microbiol 44 (2005) 59-68
3. Kyd J.M., Cripps A.W., Novotny L.A., and Bakaletz L.O. Efficacy of the 26-kilodalton outer membrane protein and two P5 fimbrin-derived immunogens to induce clearance of nontypeable Haemophilus influenzae from the rat middle ear and lungs as well as from the chinchilla middle ear and nasopharynx. Infect Immun 71 (2003) 4691-4699
4. Moore R., Lidbury B.A., Cripps A.W., and Kyd J.M. Viral co-infection does not reduce efficacy of vaccination against nontypeable Haemophilus influenzae middle ear infection in a rat model. J Otorhinolaryngol 63 (2001) 96-101
5. Kyd J., John A., Cripps A.W., and Murphy T.F. Investigation of mucosal immunisation in pulmonary clearance of Moraxella catarrhalis. Vaccine 18 (2000) 398-406
6. Briles D.E., Crain M.J., Gray B.M., Forman C., and Yother J. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect Immun 60 (1992) 111-116
7. Eskola J., Kilpi T., Palmu A., et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 344 (2001) 403-409
8. Fireman B., Black S.B., Shinefield H.R., et al. Impact of the pneumococcal conjugated vaccine on otitis media. Pediatr Infect Dis J 22 (2003) 10-16
9. Black S., Shinefield H., Fireman B., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 19 (2000) 187-195
10. Kilpi T., Ahman H., Jokinen J., et al. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: Randomized, controlled trial of a 7 valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Clin Infect Dis 37 (2003) 1155-1164
11. Veenhoven R., Bogaert D., Uiterwaal C., et al. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet 361 (2003) 2189-2195
12. van Kempen M.J., Vermeiren J.S., Vaneechoutte M., et al. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?. Int J Pediatr Otorhinolaryngol 70 (2006) 275-285
13. Dagan R., Sikular-Cohen M., Zamir O., Janco J., Givon-Levi N., and Fraser D. Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory disease infections and antibiotic use in day-care center attendees. Pediatr Infect Dis J 20 (2001) 951-958
14. Hotomi M., Ikeda Y., Suzumoto M., Yamauchi K., Green B.A., Zlotnick G., et al. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization. Vaccine 23 10 (2005) 1294-1300